Understanding Breast Changes
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
Breast Cancer Screening HEDIS Tip Sheet
HEDIS® Tip Sheet Effectiveness of Care Measure Breast Cancer Screening Breast cancer is the most common type of cancer, and the second leading cause of cancer-related deaths among women in the United States. Approximately 237,000 cases of breast cancer are diagnosed in women, and about 41,000 women die each year of breast cancer.1 Mammography is an effective screening tool for early detection of breast cancer and reduction of breast cancer mortality. California Health & Wellness want to help your practice increase Healthcare Effectiveness Data and Information Set (HEDIS®) rates. This tip sheet outlines key details of the Breast Cancer Screening (BCS) measure, its codes and guidance for documentation. Measure Women ages 50–74 who had a mammogram to screen for breast cancer in the past two years.2 Exclusions: • Patients who meet the following – A unilateral mastectomy criteria anytime during the without a modifier and measurement year: a left mastectomy with – Medicare patients ages 66 and service dates 14 days or older enrolled in an institutional more apart. special needs plans (I-SNP) or – A unilateral mastectomy living long-term in an institution. without a modifier and a – Patients ages 66 and older with right mastectomy with service frailty and advanced illness. dates 14 days or more apart. – Patients in hospice. – Absence of the left breast and absence of the right breast on the • Patients with bilateral mastectomy. same or different dates of service. Any of the following meet the criteria – Both of the following (on the same for bilateral mastectomy: or different dates of service): – Bilateral mastectomy or history. -
EARLY DETECTION Breast Health Awareness and Clinical Breast Exam
EARLY DETECTION Breast Health Awareness and Clinical Breast Exam Knowledge Summary EARLY DETECTION Breast Health Awareness and Clinical Breast Exam INTRODUCTION KEY SUMMARY Early diagnosis of breast cancer begins with the establish- Early detection programs ment of programs to improve early detection of symptomatic ¬ Early diagnosis of breast cancer can improve survival, lower women, or women with breast lumps that patients and their morbidity and reduces the cost of care when followed by a providers can feel. Early recognition of symptoms and accu- prompt diagnosis and effective treatment. rate diagnosis of breast cancer can result in cancers being diagnosed at earlier stages when treatment is more feasible, ¬ An effective early diagnosis program includes: affordable and effective. This requires that health systems √ Breast health awareness education. have trained frontline personnel who are able to recognize the √ Reducing barriers to accessing care. signs and symptoms of breast abnormalities for both benign √ Clinical breast exam (CBE) performed by primary care breast issues as well as cancers, perform clinical breast exam providers. (CBE) and know the proper referral protocol when diagnostic √ Timely diagnosis for all women found to have abnormal workup is warranted. Women who can identify breast abnor- findings and timely treatment for all women proven by malities, who have timely access to health clinical evaluation, tissue diagnosis to have breast cancer. diagnosis and treatment and who are empowered to seek this √ If supported by evidence, a quality screening mammogra- care are more likely to be diagnosed at an earlier stage (see phy program performed in a cost-effective, resource-sus- Planning: Improving Access to Breast Cancer Care). -
Vasospasm of the Nipple
Vasospasm of the Nipple A spasm of blood vessels (vasospasm) in the nipple can result in nipple and/or breast pain, particularly within 30 minutes after a breastfeeding or a pumping session. It usually happens after nipple trauma and/or an infection. Vasospasms can cause repeated disruption of blood flow to the nipple. Within seconds or minutes after milk removal, the nipple may turn white, red, or purple, and a burning or Community stabbing pain is felt. Occasionally women feel a tingling sensation or itching. As the Breastfeeding nipple returns to its normal color, a throbbing pain may result. Color change is not Center always visible. 5930 S. 58th Street If there is a reason for nipple damage (poor latch or a yeast overgrowth), the cause (in the Trade Center) Lincoln, NE 68516 needs to be addressed. This can be enough to stop the pain. Sometimes the (402) 423-6402 vasospasm continues in a “vicious” cycle, as depicted below. While the blood 10818 Elm Street vessels are constricted, the nipple tissue does not receive enough oxygen. This Rockbrook Village causes more tissue damage, which can lead to recurrent vasospasm, even if the Omaha, NE 68144 (402) 502-0617 original cause of damage is “fixed.” For additional information: (Poor Latch or Inflammation) www ↓ Tissue Damage ↙ ↖ Spasm of blood vessels → Lack of oxygen to tissues To promote improved blood flow and healing of the nipple tissue: • See a lactation consultant (IBCLC) or a breastfeeding medicine specialist for help with latch and/or pumping to reduce future nipple damage. • When your baby comes off your nipple, or you finish a pumping session, immediately cover your nipple with a breast pad or a towel to keep it warm and dry. -
Breast Scintimammography
CLINICAL MEDICAL POLICY Policy Name: Breast Scintimammography Policy Number: MP-105-MD-PA Responsible Department(s): Medical Management Provider Notice Date: 11/23/2020 Issue Date: 11/23/2020 Effective Date: 12/21/2020 Next Annual Review: 10/2021 Revision Date: 09/16/2020 Products: Gateway Health℠ Medicaid Application: All participating hospitals and providers Page Number(s): 1 of 5 DISCLAIMER Gateway Health℠ (Gateway) medical policy is intended to serve only as a general reference resource regarding coverage for the services described. This policy does not constitute medical advice and is not intended to govern or otherwise influence medical decisions. POLICY STATEMENT Gateway Health℠ does not provide coverage in the Company’s Medicaid products for breast scintimammography. The service is considered experimental and investigational in all applications, including but not limited to use as an adjunct to mammography or in staging the axillary lymph nodes. This policy is designed to address medical necessity guidelines that are appropriate for the majority of individuals with a particular disease, illness or condition. Each person’s unique clinical circumstances warrant individual consideration, based upon review of applicable medical records. (Current applicable Pennsylvania HealthChoices Agreement Section V. Program Requirements, B. Prior Authorization of Services, 1. General Prior Authorization Requirements.) Policy No. MP-105-MD-PA Page 1 of 5 DEFINITIONS Prior Authorization Review Panel – A panel of representatives from within the Pennsylvania Department of Human Services who have been assigned organizational responsibility for the review, approval and denial of all PH-MCO Prior Authorization policies and procedures. Scintimammography A noninvasive supplemental diagnostic testing technology that requires the use of radiopharmaceuticals in order to detect tissues within the breast that accumulate higher levels of radioactive tracer that emit gamma radiation. -
Primary Screening for Breast Cancer with Conventional Mammography: Clinical Summary
Primary Screening for Breast Cancer With Conventional Mammography: Clinical Summary Population Women aged 40 to 49 y Women aged 50 to 74 y Women aged ≥75 y The decision to start screening should be No recommendation. Recommendation Screen every 2 years. an individual one. Grade: I statement Grade: B Grade: C (insufficient evidence) These recommendations apply to asymptomatic women aged ≥40 y who do not have preexisting breast cancer or a previously diagnosed high-risk breast lesion and who are not at high risk for breast cancer because of a known underlying genetic mutation Risk Assessment (such as a BRCA1 or BRCA2 gene mutation or other familial breast cancer syndrome) or a history of chest radiation at a young age. Increasing age is the most important risk factor for most women. Conventional digital mammography has essentially replaced film mammography as the primary method for breast cancer screening Screening Tests in the United States. Conventional digital screening mammography has about the same diagnostic accuracy as film overall, although digital screening seems to have comparatively higher sensitivity but the same or lower specificity in women age <50 y. For women who are at average risk for breast cancer, most of the benefit of mammography results from biennial screening during Starting and ages 50 to 74 y. While screening mammography in women aged 40 to 49 y may reduce the risk for breast cancer death, the Stopping Ages number of deaths averted is smaller than that in older women and the number of false-positive results and unnecessary biopsies is larger. The balance of benefits and harms is likely to improve as women move from their early to late 40s. -
Breast Reconstruction with Expanders and Implants
Evidence-Based Clinical Practice Guideline: Breast Reconstruction with Expanders and Implants INTRODUCTION Disclaimer Evidence-based guidelines are strategies for patient management, The American Cancer Society estimates that nearly 230,000 American developed to assist physicians in clinical decision making. This women were diagnosed with invasive breast cancer in 2011.1 Many of guideline was developed through a comprehensive review of the these individuals will require mastectomy and total reconstruction of scientific literature and consideration of relevant clinical experience, the breast. The diagnosis and subsequent process can create signifi- and describes a range of generally acceptable approaches to diagnosis, cant confusion and distress for the affected persons and their families management, or prevention of specific diseases or conditions. This and, consequently, surgical treatment and reconstructive procedures guideline attempts to define principles of practice that should are of utmost importance in the breast cancer care continuum. In generally meet the needs of most patients in most circumstances. 2011, the American Society of Plastic Surgeons® (ASPS) reported an increase in the rate of breast reconstructions, citing nearly 100,000 However, this guideline should not be construed as a rule, nor procedures, of which the majority employed expanders/implants.2 should it be deemed inclusive of all proper methods of care The 3% increase in reconstructions over the course of just one year or exclusive of other methods of care reasonably directed at highlights the significance of maintaining patient safety and obtaining the appropriate results. It is anticipated that it will be optimizing surgical outcomes. necessary to approach some patients’ needs in different ways. -
Areola-Sparing Mastectomy: Defining the Risks
COLLECTIVE REVIEWS Areola-Sparing Mastectomy: Defining the Risks Alan J Stolier, MD, FACS, Baiba J Grube, MD, FACS The recent development and popularity of skin-sparing to actual risk of cancer arising in the areola and is pertinent mastectomy (SSM) is a likely byproduct of high-quality to any application of ASM in prophylactic operations. autogenous tissue breast reconstruction. Numerous non- 7. Based on clinical studies, what are the outcomes when randomized series suggest that SSM does not add to the risk some degree of nipple-areola complex (NAC) is preserved of local recurrence.1–3 Although there is still some skepti- as part of the surgical treatment? cism,4 SSM has become a standard part of the surgical ar- mamentarium when dealing with small or in situ breast ANATOMY OF THE AREOLA cancers requiring mastectomy and in prophylactic mastec- In 1719, Morgagni first observed that there were mam- tomy in high-risk patients. Some have suggested that SSM mary ducts present within the areola. In 1837, William also compares favorably with standard mastectomy for Fetherstone Montgomery (1797–1859) described the 6 more advanced local breast cancer.2 Recently, areola- tubercles that would bare his name. In a series of schol- sparing mastectomy (ASM) has been recommended for a arly articles from 1970 to 1974, William Montagna and similar subset of patients in whom potential involvement colleagues described in great detail the histologic anat- 7,8 by cancer of the nipple-areola complex is thought to be low omy of the nipple and areola. He noted that there was or in patients undergoing prophylactic mastectomy.5 For “confusion about the structure of the glands of Mont- ASM, the assumption is that the areola does not contain gomery being referred to as accessory mammary glands glandular tissue and can be treated the same as other breast or as intermediates between mammary and sweat 9 skin. -
Surgical Options for Breast Cancer
The Breast Center Smilow Cancer Hospital 20 York Street, North Pavilion New Haven, CT 06510 Phone: (203) 200-2328 Fax: (203) 200-2075 SURGICAL OPTIONS There are a number of surgical procedures available today for the treatment of breast cancer. You will likely have a choice and will need to make your own decision, in consultation with your specific surgeon, about the best option for you. We offer you a choice because the research on the treatment of breast cancer has clearly shown that the cure and survival rates are the same regardless of what you choose. The choices can be divided into breast conserving options (i.e. lumpectomy or partial mastectomy) or breast removing options (mastectomy). A procedure to evaluate your armpit (axillary) lymph nodes will likely occur at the same time as your breast surgery. This is done to help determine the likelihood that cells from your breast cancer have left the breast and spread (metastasized) to another more dangerous location. This information will be used to help decide about your need for chemotherapy or hormone blocking drugs after surgery. PARTIAL MASTECTOMY (LUMPECTOMY) A partial mastectomy involves removing the cancer from your breast with a rim, or margin, of normal breast tissue. This allows the healthy noncancerous part of your breast to be preserved, and usually will not alter the sensation of the nipple. The benefit of this surgical choice is that it often preserves the cosmetics of the breast. Your surgeon will make a decision about the volume of tissue that needs removal in order to maximize the chance of clear margins as confirmed by our pathologist. -
FAQ026 -- Benign Breast Problems and Conditions
AQ The American College of Obstetricians and Gynecologists FREQUENTLY ASKED QUESTIONS FAQ026 fGYNECOLOGIC PROBLEMS Benign Breast Problems and Conditions • What is breast tissue made of? • What kinds of changes occur in breast tissue throughout life? • What are benign breast problems? • What are fibrocystic breast changes? • Is there treatment for fibrocystic breast changes? • What are breast cysts? • How are breast cysts treated? • What are fibroadenomas? • How are fibroadenomas treated? • What is mastitis? • How is mastitis treated? • What should I do if I find a lump in my breast? • What is mammography? • What happens if a suspicious lump or area is found during a routine screening mammogram? • What happens if the results of the follow-up tests to my routine screening tests are abnormal? • Glossary What is breast tissue made of? Your breasts are made up of glands, fat, and fibrous tissue. Each breast has 15–20 sections called lobes. Each lobe has many smaller lobules. The lobules end in dozens of tiny glands that can produce milk. What kinds of changes occur in breast tissue throughout life? Your breasts respond to changes in levels of the hormones estrogen and progesterone during your menstrual cycle, pregnancy, breastfeeding, and menopause. Hormones cause a change in the amount of fluid in the breasts. This may make the breasts feel more sensitive or painful. You may notice changes in your breasts if you use hormonal contraception such as birth control pills or hormone therapy. What are benign breast problems? Benign breast problems are breast problems that are not cancerous. There are four common benign breast problems: 1. -
Side-Branching in the Mammary Gland: the Progesterone–Wnt Connection
Downloaded from genesdev.cshlp.org on September 27, 2021 - Published by Cold Spring Harbor Laboratory Press PERSPECTIVE Side-branching in the mammary gland: the progesterone–Wnt connection Gertraud W. Robinson,1 Lothar Hennighausen, and Peter F. Johnson2 Laboratory of Genetics and Physiology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-0822 USA; 2Eukaryotic Transcriptional Regulation Section, Regulation of Cell Growth Laboratory, National Cancer Institute-Frederick Cancer Research Development Center (FCRDC), Frederick, Maryland 21702-1201 USA The mammary gland is a derivative of the ectoderm mammary ducts during puberty and pregnancy. Their whose development begins in the embryo and progresses studies demonstrate that a nuclear signal is converted after birth. The major part of development occurs in the into a secreted signal that can control the fate of adjacent adolescent and adult animal. Hormones produced by the cells in a paracrine fashion. A genetic understanding of pituitary, the ovaries, the uterus, the placenta, and the this and other signaling pathways regulating cell growth mammary gland itself control this process. Over the past in the mammary gland will improve our ability to ma- century, surgical, biological, and genetic tools have been nipulate these processes and thus design strategies for used to gain insight into physiological and pathological prevention and treatment of breast cancer. processes in the mammary gland. Originally, endocrine ablation and reconstitution experiments provided a de- scriptive framework of the role of ovarian and pituitary Tools to investigate signaling pathways hormones (Halban 1900; Nandi 1958). These experi- Several features of the mammary gland provide unique ments demonstrated a clear requirement for the ovarian opportunities for experimental manipulations to inte- steroids estrogen and progesterone for ductal growth and grate systemic, local and cell-specific signaling path- alveolar development (Topper and Freeman 1980). -
Breast Cancer Treatment What You Should Know Ta Bl E of C Onte Nts
Breast Cancer Treatment What You Should Know Ta bl e of C onte nts 1 Introduction . 1 2 Taking Care of Yourself After Your Breast Cancer Diagnosis . 3 3 Working with Your Doctor or Health Care Provider . 5 4 What Are the Stages of Breast Cancer? . 7 5 Your Treatment Options . 11 6 Breast Reconstruction . 21 7 Will Insurance Pay for Surgery? . 25 8 If You Don’t Have Health Insurance . 26 9 Life After Breast Cancer Treatment . 27 10 Questions to Ask Your Health Care Team . 29 11 Breast Cancer Hotlines, Support Groups, and Other Resources . 33 12 Definitions . 35 13 Notes . 39 1 Introducti on You are not alone. There are over three million breast cancer survivors living in the United States. Great improvements have been made in breast cancer treatment over the past 20 years. People with breast cancer are living longer and healthier lives than ever before and many new breast cancer treatments have fewer side effects. The New York State Department of Health is providing this information to help you understand your treatment choices. Here are ways you can use this information: • Ask a friend or someone on your health care team to read this information along with you, or have them read it and talk about it with you when you feel ready. • Read this information in sections rather than all at once. For example, if you have just been diagnosed with breast cancer, you may only want to read Sections 1-4 for now. Sections 5-8 may be helpful while you are choosing your treatment options, and Section 9 may be helpful to read as you are finishing treatment. -
Breast Infection
Breast infection Definition A breast infection is an infection in the tissue of the breast. Alternative Names Mastitis; Infection - breast tissue; Breast abscess Causes Breast infections are usually caused by a common bacteria found on normal skin (Staphylococcus aureus). The bacteria enter through a break or crack in the skin, usually the nipple. The infection takes place in the parenchymal (fatty) tissue of the breast and causes swelling. This swelling pushes on the milk ducts. The result is pain and swelling of the infected breast. Breast infections usually occur in women who are breast-feeding. Breast infections that are not related to breast-feeding must be distinguished from a rare form of breast cancer. Symptoms z Breast pain z Breast lump z Breast enlargement on one side only z Swelling, tenderness, redness, and warmth in breast tissue z Nipple discharge (may contain pus) z Nipple sensation changes z Itching z Tender or enlarged lymph nodes in armpit on the same side z Fever Exams and Tests In women who are not breast-feeding, testing may include mammography or breast biopsy. Otherwise, tests are usually not necessary. Treatment Self-care may include applying moist heat to the infected breast tissue for 15 to 20 minutes four times a day. Antibiotic medications are usually very effective in treating a breast infection. You are encouraged to continue to breast-feed or to pump to relieve breast engorgement (from milk production) while receiving treatment. Outlook (Prognosis) The condition usually clears quickly with antibiotic therapy. Possible Complications In severe infections, an abscess may develop. Abscesses require more extensive treatment, including surgery to drain the area.